Carillon Tower Advisers' Q2 2024 investor letter discusses the market performance and highlights AstraZeneca PLC (NASDAQ:AZN) as a promising stock pick. The letter emphasizes the potential of AI stocks for higher returns and provides insights on hedge fund portfolios.